OABI
OmniAb, Inc.NASDAQHealthcare$1.54-1.28%ClosedMarket Cap: $175.3M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.74
P/S
9.39
EV/EBITDA
-3.59
DCF Value
$-0.38
FCF Yield
-21.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
73.5%
Operating Margin
-383.1%
Net Margin
-347.0%
ROE
-24.0%
ROA
-21.5%
ROIC
-24.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $8.4M | 99.9% | $-18.3M | $-14.2M | $-0.11 | — |
| FY 2025 | $18.7M | -18.2% | $-71.5M | $-64.8M | $-0.57 | — |
| Q3 2025 | $2.2M | -109.2% | $-18.2M | $-16.5M | $-0.14 | — |
| Q2 2025 | $3.9M | 93.3% | $-16.2M | $-15.9M | $-0.15 | — |
| Q1 2025 | $4.2M | 100.0% | $-18.8M | $-18.2M | $-0.17 | — |
| Q4 2024 | $10.8M | 100.0% | $-15.9M | $-13.1M | $-0.12 | — |
| FY 2024 | $26.4M | 100.0% | $-74.5M | $-62.0M | $-0.61 | — |
| Q3 2024 | $4.2M | 100.0% | $-19.8M | $-16.4M | $-0.16 | — |
| Q2 2024 | $7.6M | 100.0% | $-16.3M | $-13.6M | $-0.13 | — |
| Q1 2024 | $3.8M | 100.0% | $-22.6M | $-19.0M | $-0.19 | — |
| Q4 2023 | $4.8M | 100.0% | $-21.2M | $-14.1M | $-0.14 | — |
| FY 2023 | $34.2M | 100.0% | $-69.4M | $-50.6M | $-0.51 | — |